Pfizer agreed to pay nearly $60 million to resolve allegations that its Biohaven Pharmaceuticals unit paid kickbacks to entice physicians to prescribe a migraine treatment.
Dozens of scientists traveled to San Francisco this week for an unremarkable conference with federal research officials. On Wednesday, the day before it was set
The Trump administration has appointed a veteran infectious disease researcher who was critical of the U.S. response to the Covid-19 pandemic as acting head of
Vancouver, British Columbia–(Newsfile Corp. – January 24, 2025) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (“Entheon” or the “Company“) is pleased to announce
VANCOUVER, BC, Jan. 23, 2025 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health
Toronto, Ontario–(Newsfile Corp. – January 22, 2025) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s
Vancouver, British Columbia – TheNewswire – 21 January, 2025 – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6), (the “Company” or “MindBio”), a clinical stage biopharmaceutical company specialising in psychedelic microdosing today
Vancouver, British Columbia, January 21, 2025 – Filament Health Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, today announced that
Rua Bioscience announced its support for a clinical study that harnesses the potential of psilocybin-containing mushrooms to treat methamphetamine addiction. This pioneering research, rooted in